Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: Ingenuity Variant Analysis an d iReport, InSilico DB Chimera 1.9, and more


Qiagen Redwood City, formerly Ingenuity, said this week that it has integrated the Ingenuity Variant Analysis and Ingenuity iReport software with the InSilico DB data management platform. This provides InSilico's users with access to the Ingenuity applications and lets Qiagen's customers explore their private datasets in the context of the sequencing data provided by InSilico DB.

Chimera 1.9, a molecular modeling system developed by researchers at the University of California, San Francisco, is available here.

New features in this release include multiple sequence alignment using Clustal Omegaor MUSCLE web services; the ability to build double-helical nucleic acids; more efficient save/restore of coordinates in sessions; a Dynameomics amino acid rotamer library; and more.

The bioinformatics group at the University of California, Santa Cruz, has released a new genes track for the GRCh38/hg38 human genome browser. The new release has 104,178 transcripts, compared with 82,960 in the previous version on hg19. The total number of canonical genes also increased from 31,848 to 48,424.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.